Back to Trades
Fitzgerald Kevin Joseph
InsiderCIK 0001886431
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 86
- Companies
- 2
- Active
- 2025–2026
Across 8 filings between 2025–2026, Fitzgerald Kevin Joseph has disclosed $16.0M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $11.4M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Apr 9 | OVID Ovid Therapeutics Inc. | Fitzgerald Kevin Joseph | Insider | Grant | $45.0K |
| Mar 6 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $417.7K |
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $1.1M |
| Feb 17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $1.3M |
| Jan 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $1.4M |
| Nov 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $5.5M |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $1.1M |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $632.8K |
8 filings